Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Coya Therapeutics (COYA) Shares Outstanding (Weighted Average) (2022 - 2025)

Historic Shares Outstanding (Weighted Average) for Coya Therapeutics (COYA) over the last 4 years, with Q3 2025 value amounting to $16.7 million.

  • Coya Therapeutics' Shares Outstanding (Weighted Average) rose 992.99% to $16.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.7 million, marking a year-over-year increase of 992.99%. This contributed to the annual value of $15.2 million for FY2024, which is 4993.25% up from last year.
  • According to the latest figures from Q3 2025, Coya Therapeutics' Shares Outstanding (Weighted Average) is $16.7 million, which was up 992.99% from $16.7 million recorded in Q2 2025.
  • In the past 5 years, Coya Therapeutics' Shares Outstanding (Weighted Average) registered a high of $16.7 million during Q3 2025, and its lowest value of $2.6 million during Q1 2022.
  • For the 4-year period, Coya Therapeutics' Shares Outstanding (Weighted Average) averaged around $10.7 million, with its median value being $10.2 million (2023).
  • In the last 5 years, Coya Therapeutics' Shares Outstanding (Weighted Average) skyrocketed by 29240.04% in 2023 and then soared by 992.99% in 2025.
  • Quarter analysis of 4 years shows Coya Therapeutics' Shares Outstanding (Weighted Average) stood at $2.6 million in 2022, then soared by 292.4% to $10.2 million in 2023, then surged by 49.93% to $15.2 million in 2024, then rose by 9.8% to $16.7 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $16.7 million in Q3 2025, compared to $16.7 million in Q2 2025 and $16.7 million in Q1 2025.